Original language | American English |
---|---|
State | Published - 2023 |
Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors. #CT275: AACR ProcVol 83; (8_Supplement): CT275. AACR meeting Orlando, FL, 2023.
B Carneiro, Rachel Sanborn, Dave S.B. Hoon, See all authors in notes
Research output: Contribution to conference › Abstract